| |
| |
|
| Insider
Information: |
Kung Frank |
| Relationship: |
|
| City: |
Schaumburg |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
116,909 |
|
|
Indirect Shares
|
7,831,495 |
|
|
| Direct
Value |
$160 |
|
|
|
Indirect Value
|
$5,094 |
|
|
| Total
Shares |
7,948,404 |
|
|
| Total
Value |
$5,254 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 194.9%
|
 -64.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sagent Pharmaceuticals Inc |
SGNT |
Director |
2015-02-22 |
36,909 |
2015-02-22 |
7,799,737 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2014-11-12 |
31,758 |
Premium* |
|
|
Amyris, Inc. |
AMRS |
|
2022-09-21 |
80,000 |
2024-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRS |
Amyris, Inc. |
|
– • – |
2024-05-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,750,828) |
0 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2018-08-17 |
4 |
OE |
$4.26 |
$22,032,979 |
I/I |
5,042,437 |
617,877 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2021-04-13 |
4 |
S |
$14.96 |
$70,000,006 |
I/I |
(4,678,363) |
711,258 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2020-06-05 |
4 |
B |
$3.00 |
$11,067,675 |
I/I |
3,689,225 |
551,884 |
2.1 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2018-08-17 |
4 |
S |
$6.22 |
$17,268,128 |
I/I |
(2,776,762) |
139,306 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2021-04-13 |
4 |
OE |
$4.26 |
$8,279,987 |
I/I |
1,943,659 |
1,168,689 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2018-08-20 |
4 |
OE |
$4.40 |
$7,175,758 |
I/I |
1,630,854 |
676,448 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-09-15 |
4 |
AS |
$4.20 |
$5,817,000 |
I/I |
(1,385,000) |
458,591 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2021-04-14 |
4 |
OE |
$4.76 |
$5,772,866 |
I/I |
1,212,787 |
938,416 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2013-09-16 |
4 |
S |
$21.25 |
$24,686,486 |
I/I |
(1,161,717) |
4,180,791 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2018-08-20 |
4 |
S |
$6.22 |
$7,139,941 |
I/I |
(1,148,122) |
478,571 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-09-19 |
4 |
AS |
$3.80 |
$4,106,569 |
I/I |
(1,080,676) |
109,460 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2019-04-29 |
4 |
B |
$4.76 |
$4,348,398 |
I/I |
913,529 |
787,259 |
2.1 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-09-16 |
4 |
AS |
$3.60 |
$2,999,160 |
I/I |
(833,100) |
306,608 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-09-20 |
4 |
AS |
$3.60 |
$1,440,000 |
I/I |
(400,000) |
36,488 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-09-21 |
4 |
AS |
$3.50 |
$700,000 |
I/I |
(200,000) |
0 |
0 |
% |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-08-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
80,000 |
87,409 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-08-22 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,000 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2011-04-20 |
4 |
B |
$16.00 |
$320,000 |
D/D |
20,000 |
26,379 |
2.39 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2021-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,409 |
7,409 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-08-23 |
4/A |
D |
$0.00 |
$0 |
D/D |
(7,409) |
80,000 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2022-08-23 |
4/A |
A |
$0.00 |
$0 |
I/I |
7,409 |
16,207 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
OE |
$4.23 |
$13,494 |
D/D |
3,190 |
29,569 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2012-06-01 |
4 |
OE |
$4.23 |
$13,494 |
D/D |
3,190 |
32,759 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
4,266 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
